￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Survival period and drug resistance after taking ixazomib

2026-02-01 22:25:32

Check Details
Ixazomib targeted drug for multiple myeloma

2026-02-01 22:25:32

Check Details
Can ixazomib and lenalidomide be taken at the same time?

2026-02-01 22:25:32

Check Details
How effective is ixazomib?

2026-02-01 22:25:32

Check Details
Ixazomib effects and side effects

2026-02-01 22:25:32

Check Details
Discussion on the treatment duration of Valganciclovir: Varies depending on the condition and individual differences

2026-02-01 22:25:32

Check Details
What conditions can Valganciclovir treat?

2026-02-01 22:25:32

Check Details
Analysis of the therapeutic effect of Valganciclovir on cytomegalovirus infection

2026-02-01 22:25:32

Check Details
Detailed guidance on the use of the antiviral drug Valganciclovir in children

2026-02-01 22:25:32

Check Details
Detailed explanation of the side effects of tepotinib in the treatment of lung cancer and its coping strategies

2026-02-01 22:25:32

Check Details
Analysis of tepotinib resistance problems and countermeasures

2026-02-01 22:25:32

Check Details
Tepotinib for the treatment of lung cancer: Medication guidelines that patients must know

2026-02-01 22:25:32

Check Details
Category
相关知识